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Abstract
Background: Patient and public engagement (PPE) in research is growing internationally, and with it, the interest
for its evaluation. In Canada, the Strategy for Patient-Oriented Research has generated national momentum and
opportunities for greater PPE in research and health-system transformation. As is the case with most countries, the
Canadian research community lacks a common evaluation framework for PPE, thus limiting our capacity to ensure
integrity between principles and practices, learn across projects, identify common areas for improvement, and
assess the impacts of engagement.
Objective: This project aims to build a national adaptable framework for the evaluation of PPE in research, by:
1. Building consensus on common evaluation criteria and indicators for PPE in research;
2. Defining recommendations to implement and adapt the framework to specific populations.
Methods: Using a collaborative action-research approach, a national coalition of patient-oriented research leaders,
(patient and community partners, engagement practitioners, researchers and health system leaders) will co-design
the evaluation framework. We will develop core evaluation domains of the logic model by conducting a series of
virtual consensus meetings using a nominal group technique with 50 patient partners and engagement
practitioners, identified through 18 national research organizations. We will then conduct two Delphi rounds to
prioritize process and impact indicators with 200 participants purposely recruited to include respondents from
seldom-heard groups. Six expert working groups will define recommendations to implement and adapt the
framework to research with specific populations, including Indigenous communities, immigrants, people with
intellectual and physical disabilities, caregivers, and people with low literacy. Each step of framework development
will be guided by an equity, diversity and inclusion approach in an effort to ensure that the participants engaged,
the content produced, and the adaptation strategies proposed are relevant to diverse PPE.
(Continued on next page)
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: Antoine.boivin@umontreal.ca
1Center of Excellence for Partnership with patients and the public, University
of Montreal Hospital Research Center (CRCHUM), Montreal, Canada
2Canada Research Chair in Partnership with Patients and the Public,
University of Montreal Hospital Research Center, Montreal, Canada
Full list of author information is available at the end of the article
L’Espérance et al. Research Involvement and Engagement            (2021) 7:10 
https://doi.org/10.1186/s40900-021-00255-4
(Continued from previous page)
Discussion: The potential contributions of this project are threefold: 1) support a national learning environment for
engagement by offering a common blueprint for collaborative evaluation to the Canadian research community; 2)
inform the international research community on potential (virtual) methodologies to build national consensus on
common engagement evaluation frameworks; and 3) illustrate a shared attempt to engage patients and researchers
in a strategic national initiative to strengthen evaluation capacity for PPE.
Keywords: Patient and public engagement, Patient-oriented research, Participatory action-research, Evaluation
Plain English summary
Patients and members of the public increasingly partici-
pate as partners in health and health care research. How-
ever, evaluation of such initiatives are rare. This limits
what we know about how to better engage with people.
The goal of this project is to develop a national framework
to evaluate patient and public engagement in Canada. We
aim to provide local teams with a common blueprint to
evaluate engagement activities. We will bring together pa-
tients, community partners, researchers, and health system
leaders across Canada to create this evaluation framework.
We will build consensus using online workshops with vot-
ing and prioritizing exercises. At each step in the process,
we will seek participants with diverse backgrounds and
health care experiences, such as, people from Indigenous
communities, immigrants and newcomers, people with in-
tellectual or physical disabilities, and people with lower
levels of literacy. Participants will also contribute different
perspectives as researchers, patients and caregivers. Know-
ing that certain groups encounter barriers to participation,
patients will help design both methods and content for
the research activities. Finally, expert working groups, co-
led by researchers with patients and community members,
will recommend how to adapt the framework for specific
populations and seldom-heard groups. We expect this
project to improve patient and public engagement by
helping teams to reflect on their engagement initiatives. It
is also an example of building consensus for evaluation
that could inspire researchers in other countries.
Introduction
Patient and public engagement (PPE)1 in research is
growing internationally, and so is interest in its evalu-
ation. Around the world, the health research community
increasingly recognizes the need to engage with a wider
diversity of patients and communities, in a way that is
relevant, meaningful, reciprocal and impactful. There is
a need for robust evaluation and stronger evidence
regarding PPE in research, from accountability, scientific
and continuous improvement perspectives. Several au-
thors (e.g. [2, 6, 14, 28, 29]) describe how the knowledge
gap between “what we want to achieve” and “what we
know we achieved” can negatively affect those who are
skeptical of the benefits of PPE in research (fuelling their
reluctance to engage), but can also hinder the work of
those who are convinced of its importance (limiting their
efforts to improve engagement practices over time). The
call for sound evaluation resonates both with those ap-
proaching engagement from a normative perspective
(seeing engagement as having intrinsic value) or from an
instrumental perspective (seeing engagement as a means
to an end) [7, 8].
In 2019, a systematic review of patient and public en-
gagement evaluation frameworks was conducted by
Greenhalgh and colleagues [15]. It showed how diverse
and theoretically heterogeneous this literature is. Their
final data set consisted of 65 evaluation frameworks. The
authors concluded that the diversity in purposes and sci-
entific underpinning of existing frameworks limited trans-
ferability across contexts. They concluded that “a single,
one-size-fits-all framework may be less useful than a range
of resources that can be adapted and combined in a locally
generated co-design activity” developed with patient col-
laborators [15]. Whether and to what extent a diverse set
of stakeholders (e.g. patients, researchers, health system
leaders) can agree on a common evaluation framework for
patient and public engagement, and how such consensus
can be achieved, remains an open question.
Objectives
This article reports on the protocol of a funded study,
whose primary goal is to develop a national adaptable
framework for the evaluation of PPE in research. Specific
objectives are to:
1. Build consensus within the Canadian research
community on the core evaluation criteria, process
and impact indicators of PPE in research;
2. Define experts’ recommendations on the
implementation of the evaluation framework and its
1For this project we adopt the Canadian Institute of Health Research
(2019) definition of patient engagement: “Patient engagement in
research is an approach that involves meaningful and active
collaboration in governance, priority setting, conducting research and
knowledge translation. Depending on the context, patient engagement
may also engage people who bring the collective voice of specific,
affected communities.” 2.
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adaptation to different populations, with a focus on
equity, inclusion and diversity.
The PPE evaluation framework is intended to serve
as a common minimal structure around which the
Canadian research community will be able to build
their own evaluation initiatives; thereby promoting
comparability across evaluations, while allowing for
flexibility and adaptation to different populations and
contexts. Our intention is to offer enough supporting
theory and guidance for research organizations and
partners to build their own evaluation in a way that:
1) aligns with common engagement principles out-
lined in the Canadian Strategy for Patient-Oriented
Research; 2) is adaptable to specific contexts of en-
gagement (settings, populations, type and domains of
research, etc.), and 3) allows for mutual learning and
understanding across projects and organizations by
defining core evaluation standards applicable across
Canada.
Canadian context
The Canadian Institutes of Health Research’s (CIHR)
Strategy for Patient-Oriented Research (SPOR) was
launched in 2011 to support “a continuum of research
that engages patients as partners, focusses on patient-
identified priorities and improves patient outcomes”
[10]. SPOR generated significant momentum and oppor-
tunities for greater PPE in research and health-system
transformation. Nationally, SPOR’s four principles of pa-
tient and public engagement – Inclusiveness, Support,
Mutual Respect, and Co-Building - have steered practices
of PPE and reinforced them through a set of research-
focused entities meant to build capacity for, and imple-
ment, engagement amongst researchers and their part-
ners. These SPOR funded entities include SUPPORT
Units (patient-oriented research methodology support
infrastructure, providing practical support for patient
and public engagement in research) and SPOR Networks
(national research networks focused on specific diseases
or topic areas, engaging patients and members of the
public in their operations).
While SPOR has fostered the practice of patient and
public engagement in Canadian health research, current
engagement initiatives are rarely evaluated, or are evalu-
ated with different frameworks. Lack of common evalu-
ation framework limits capacity to:
 Ensure concordance between guiding principles and
engagement practices;
 Learn across projects implemented throughout the
country;
 Monitor progress and improve practices over time
 Assess the outcomes and impacts of engagement
(what difference does it make, in which
circumstances and for whom?).
Recent developments in the field of PPE evaluation are
helping to address this gap. In collaboration with na-
tional SPOR partners, members of our research team
have published a systematic review of evaluation tools
for PPE in research [7, 8]; assembled existing instru-
ments in an open access online evaluation toolkit
(https://ceppp.ca/en/our-projects/evaluation-toolkit/);
and developed original, validated evaluation instruments
(e.g. [3, 4]). While these endeavours provide the Canad-
ian research community with a set of individual evalu-
ation instruments, we still lack a common evaluation
framework to serve as a blueprint for building collabora-
tive evaluation projects or comparing engagement prac-
tices. Existing evaluation frameworks tend to be limited
to single engagement interventions, are difficult to trans-
fer across research projects, and/or have limited applic-
ability to the Canadian research context. As a result,
published evaluations are characterized by a number of
small studies that limit our ability to build a common
knowledge base and sustain a learning environment that
builds best practices for PPE.
A national initiative like SPOR provides an opportun-
ity to develop consensus around evaluation. The level of
coordination and collaboration between SPOR entities
(Units and Networks) with respect to PPE could provide
sufficient common ground to adopt a common frame-




Using a collaborative action-research approach [22], a
national coalition of patient-oriented research leaders,
including SPOR SUPPORT Units and Research Net-
works, patient and community partners, engagement ex-
perts, and health system leaders, will collaborate to co-
design this evaluation framework. Hence, as much as
this project will build on the existing international sci-
ence of PPE evaluation, the consensus building endeav-
our will ensure that PPE evaluation is tailored to the
national context and will consolidate ongoing collabor-
ation amongst the PPE research community in Canada.
The main research phases are depicted in Fig. 1, in-
cluding: 1) development of a logic model (via consensus
meetings), 2) agreement on a core set of process and
outcome indicators (via a Delphi process) and 3) devel-
opment of implementation guidelines (via co-led expert
working groups on implementation and adaptation to
seldom-heard populations).
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Our evaluation framework development process will
be supported by international evidence based on sys-
tematic reviews of evaluation frameworks for patient
and public engagement in research [9, 11, 12, 15, 18],
a systematic review of existing evaluation instruments
[8], evaluation principles for evaluating patient and
public engagement in research [8], and a systematic
review of patient and public engagement outcome in-
dicators and evaluation methods [32]. This prepar-
ation work will be used to produce background
evidence documents for expert working group mem-
bers, to develop Delphi questionnaires and prepare
consensus meeting participants.
With this general understanding of what PPE in re-
search looks like and what the literature broadly con-
siders as successful PPE processes and impacts as a base
(e.g. [16, 17]), this project will take the next steps to de-
fine what success in PPE looks like for the Canadian re-
search community in particular. Consensus-generating
participatory methodologies will be used (Nominal
Group Technique and Delphi Method) to consolidate a
logic model and build consensus on a core set of PPE
evaluation standards. These steps will help us answer
the following questions:
1) What is meaningful PPE in research for the
Canadian research community? (Process indicators);
2) What does successful engagement look like for
stakeholders of the SPOR? (Outcome indicators);
and
3) How should we approach the evaluation of PPE
engagement in research? (Evaluation criteria)
As Rowe and Frewer [26] described, defining the term
effectiveness/success/meaningfulness is paramount to
sound evaluation. Unless there is a clear definition of
what it means for a PPE initiative to be effective/success-
ful/meaningful in a given context, it is not possible to
develop measures and methods that enable the evalu-
ation of patient and public engagement. However, not
universal in nature, the definition of what represents
success in a given context needs to be adopted by the
key potential users of the evaluation framework. For this
reason, our project will work collaboratively with en-
gagement leads, patient partners and researchers from
the Canadian SPOR community specifically to define the
parameters of these terms.
We recognize that different evaluation perspectives
may exist amongst interested parties. Although com-
peting evaluation purposes may coexist, we assume
that key partners in patient-oriented research are
more likely to measure their engagement activities
against a common set of goals if they set those goals
together, as a community. Previous studies have docu-
mented research partners’ interest in documenting
whether their collaborative efforts make a difference
in the research process (see [1]). Our research team
will build on the ongoing Canadian collaborations
around PPE within SPOR to bring about such con-
sensus and to create a common understanding around
Fig. 1 Project overview
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what a SPOR Patient Engagement Evaluation Frame-
work should look like.
Virtual consensus meeting
The first consensus-building exercise, employing the
nominal group technique, will consist of a structured fa-
cilitation strategy for group brainstorming that will allow
for a larger conversation to occur between research
stakeholders, including patient partners, engagement ex-
perts, and researchers. This will fulfill three purposes: 1)
building research community mobilization around the
construction of the framework; 2) fostering common un-
derstanding of PPE evaluation, and 3) generating ideas
about core evaluation domains of the logic model (i.e.
aligning objectives of PPE in research with evaluation
criteria; PPE process dimensions with categories of
process indicators; PPE outputs dimensions with cat-
egories of outcome indicators). The nominal group tech-
nique is a structured variation of small group discussion
methods [31]. This structured process aims at prevent-
ing discussions from being dominated by a single person
or group, by encouraging less vocal group members to
participate in the prioritization of solutions and
recommendations.
Collaboration with 18 national SPOR Networks, SUP-
PORT Units and research organizations (from all Canad-
ian provinces and covering research focus in primary
care, diabetes, chronic pain, mental health, developmen-
tal disability, chronic diseases, kidney diseases) will pro-
vide broad representation from the Canadian patient-
oriented research community, mobilizing participants
with experience on PPE in research and its evaluation.
Our consensus panel for the nominal group technique
will involve approximately 50 individuals identified
through partner organizations (Acknowledgement sec-
tion). All SPOR funded-entities will be invited to nomin-
ate two or three participants – one patient or
community partner and one engagement practitioner
(eg. research professional, engagement facilitator or re-
searcher with engagement experience), with a focus on
identifying participants with engagement expertise and a
diversity of perspectives. In addition, the meeting will in-
clude other specialists in the field of PPE, including rep-
resentatives from the Patient Advisors Network, a
patient-led community of practice bringing together ex-
perienced patient partners in research, and the Canadian
Foundation for Healthcare Improvement, a pan-
Canadian organisation dedicated to fostering research
and healthcare improvement with expertise in patient
and public engagement [13].
This event, that will consist of four virtual meetings
held at different dates, was originally intended to be held
in person. However, the advent of COVID-19 required
us to re-evaluate our original strategy. Within the
COVID-19 context, we will hold this consensus process
online, in accordance with best practice recommenda-
tions for virtual consensus-building (e.g. [24, 30]). The
consensus meeting will still include the 8 key phases of a
nominal technical group, but it will occur in sequence
over 4 virtual meetings, each of which will be carried out
with about 12 to 15 participants to facilitate group dis-
cussion and sharing. Sub-groups will run in parallel
(meetings #1-#2-#3), with summaries from discussions
shared among all participants at the plenary discussion
phase (meeting #4), as described below.
Meeting 1- preparation phase A preparation webinar
will be offered to participants. This webinar will provide
a quick overview of what is currently known about
evaluating PPE in research. This will allow participants
to have a common knowledge and understanding of the
concepts being discussed, and to clarify the project goal
and set the stage for discussion rounds. The webinar will
address what an evaluation criterion is and what evalu-
ation dimensions are, providing specific examples to the
participants. The webinar will be given live with the pos-
sibility of a questions and answers period at the end. It
will also be recorded in order for participants who won’t
be able to attend to watch it asynchronously. Comple-
mentary documents will also be available to participants
to help them prepare for the following discussions: an
outline of project objectives and timeline, a jargon bus-
ter, and a synthesis of key articles about PPE evaluation.
Ongoing communication with the team is key during
the Virtual Consensus Meeting, hence a Slack channel
(www.slack.com) will be created and facilitated by a pro-
ject team member for the duration of Phase 1 to answer
questions and orient participants.
Meeting 2- ideas generation phase Virtual Zoom
meetings of 120 min will be conducted with each sub-
group to generate ideas on evaluation criteria, process
and impact indicators. To identify evaluation criteria,
participants will be asked to define principles of PPE in
research, to describe their perspectives on what makes
PPE in research successful. To identify process dimen-
sions, participants will be asked about standards to de-
termine whether a process of PPE in research is going as
planned, and about factors that enable meaningful en-
gagement. To identify impact dimensions, participants
will discuss the changes they feel should be brought
about when patients are engaged in research and on
whom or what these change should be observed. Partici-
pants will be asked to identify standards that help deter-
mine whether a research project involving patients has
achieved the desired outcomes.
Research team members will facilitate these meetings
on several dates to accommodate a maximum number
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of participants. We will create sub-groups composed of
equal number of professionals and patient partners.
Other options will be made available to participants to
ease participation in the discussions. They will have the
opportunity, after each meetings, to send their ideas and
comments in: 1) writing (format chosen by the partici-
pant - email, word, etc.) and 2) audio (with recordings
sent to the project team and transcribed by a team
member).
Round Robin phase Verbatim transcripts of partici-
pants’ dialogue (recordings of zoom meetings, tran-
scripts and written statements) will be analyzed with the
help of Nvivo to identify specific sets of ideas, themes,
and remaining questions/needs for clarification. A sum-
mary report will be produced by the project team and
circulated amongst participants to help start the next fa-
cilitated round.
Meeting 3 - clarification phase At meeting 3, each
idea/set of ideas/themes will be discussed one at a time
in order to clarify them and/or explain disagreement
with emerging positions. These will be 120-min virtual
Zoom meetings within sub-groups. Research team mem-
bers will facilitate the meetings, with several dates pro-
posed to accommodate a maximum number of people.
We will create sub-groups composed of equal number of
professionals and patient partners.
Voting phase At the end of the clarification phase, par-
ticipants will begin to narrow the list of potential ideas.
Building on the clarification phase, each member will
rank the ideas they consider from most to least import-
ant. Zoom provides a survey application built into the
plate-form that we will use to ask for a virtual simultan-
eous vote.
Consolidation phase The top ideas from each subgroup
will be consolidated by the research team, combining
any duplicate ideas, and a master list of ideas will be
generated for the plenary discussion and final vote. This
list will be circulated amongst participants prior to the
last closing meeting.
Meeting 4 - plenary discussion A 120-min zoom meet-
ing (one date - set in advance to maximize participation)
will be held. Briefly, the facilitator will present to partici-
pants each idea for each question and their previous rat-
ings in order to examine inconsistent voting patterns
and provide an opportunity for a discussion around
these outlier ideas. Ideas with strong support will be
maintained whereas those with weak support will be
eliminated. Participants will be able to use both the
microphone and the chat box to participate in the
discussion.
Final vote A final vote will be called at the end of the
meeting on the three sets of ideas (criteria, process di-
mensions, impact dimensions), asking participants to
rank ideas generated by the group.
Meeting 2 and 3 will involve the same sub-groups of
participants to increase their sense of belonging and ease
discussion. We will try as much as possible to recreate
online the same dynamics the face-to-face setting would
have provided. For each step of the virtual consensus
meetings, a facilitator and note taker from the project
team will be facilitating the discussion. The meetings
will be recorded to ease note taking and maximize con-
tent analysis. Using the notes and transcriptions of the
meetings, we will proceed to a thematic content analysis
using Nvivo. Analysis will focus on: 1) identifying emer-
ging evaluation criteria, processes and indicators (to gen-
erate items for the Delphi priority-setting exercise); 2)
participants’ interpretation of the meaning of those cri-
teria and indicators (to inform narrative description of
indicators and criteria); and 3) areas of consensus and
dissent regarding the relative importance of emergent
indicators (to inform our analysis of whose voices were
dominant or not in generating potential indicators and
criteria).
Delphi
While the virtual consensus meeting (above) will be used
to generate potential evaluation criteria and dimensions,
a modified Delphi process will seek to identify those cri-
teria and dimensions that are most important for the
community of patient-oriented research experts. The
Delphi Technique is a well-known method for structur-
ing (organizing and facilitating) a group communication
and consensus process. It is characterized by iterative
rounds of questionnaires with systematic feedback be-
tween each round. The method allows for large pools of
individuals to be involved asynchronously at times and
locations convenient to them, while preserving their
anonymity. It also allows identification of areas of con-
vergences and dissension among stakeholder groups. For
that purpose, two rounds of online questionnaires will
seek to determine which standards (process and impact
indicators) are most important for the SPOR commu-
nity. This activity will provide a minimal evaluation
structure to be implemented throughout the SPOR
environment.
To increase the variety of expertise engaged, the par-
ticipants invited to take part in the Delphi will cover a
broad representation of the Canadian community of pa-
tient partners in research and researchers supported/in-
volved within the SPOR environment. We will aim to
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solicit 200 participants and will be helped by SPOR en-
tities to reach out to their respective members and col-
laborators to identify potential Delphi participants.
SPOR entities will be asked to identify 5 researchers who
conduct patient-oriented research in partnership with
patients as well as 5 patient partners involved in re-
search. Co-leads of our equity, diversity and inclusion
working groups (described below) will also be solicited
to identify prospective participants from seldom-heard
populations. Purposeful selection of participants will be
carried by the research team to ensure that a diversity of
perspectives are represented, both from a sociodemo-
graphic point of view and in terms of patient experience
pathway.
In Round One, we will share our interim report from
the consensus building exercise. Panelists will then be
asked to prioritize indicators for each dimension, among
the list identified during the nominal group technique
exercise. Specific prioritization techniques (rating, rank-
ing, choice of scales) will be determined by the research
team, based on the number of items emerging from the
consensus meetings and pilot testing of the Delphi sur-
vey. Participants will be invited to provide optional
qualitative justifications for their choices.
In Round Two, participants will receive a summary of
Round One results, and will be asked to provide their
final, informed priorities, using the same evaluation
techniques as used in Round One. These questions are
designed to establish the indicators that are the highest
priority for the SPOR community. In addition to identi-
fying and ranking indicators, the respondents will also
provide input on the chosen wording to identify PPE
evaluation standards. This will provide the research team
with information to complete common parts of the PPE
evaluation framework.
Turnaround time between questionnaires will be 6 weeks.
Only two rounds of questionnaires will be sent to partici-
pants, as the initial round will already be informed by the re-
sults of the consensus meeting. This should increase
participation and limit the attrition rate over the process.
We will analyze results for all participants, and by sub-
groups (eg. patient partners vs. researchers, sociodemo-
graphic characteristics) to identify areas of consensus
and dissent among all participants and for distinct
groups. These stratified analyses will inform discussions
of expert working groups on adaptation of the evaluation
framework for specific populations (below).
Expert working-groups on implementation and adaptation
While prior phases of this project will focus on general
PPE process and outcomes indicators, this approach
does not address the reality that many will face in deter-
mining the relative importance to assign to each of these
elements in the evaluation of PPE initiatives for specific
populations. We know that approaches taken to evaluat-
ing PPE differ conceptually and methodologically in re-
sponse to the different populations engaged as well as
the purpose of patient and public engagement in a given
context. Abelson and Gauvin [1] raised these crucial
questions: “how evaluation criteria or ‘elements of suc-
cess’ should be weighted in evaluation, by whom, and
whether some criteria are more important than others in
terms of their contribution to the evaluation”. (p. 7).
Therefore, in order to answer these questions, six
working groups of experts – each co-led by one re-
searcher and one patient/public partner – will work with
their respective research and patient/public partner
communities in defining recommendations for the im-
plementation and adaptation of the framework. With the
results and analysis of the consensus exercises in hand,
co-applicants (scientific and patient experts) and collab-
orators (SPOR Networks and SUPPORT Units) will be
involved in designing implementation strategies and out-
lining fundamental elements of an evaluation design,
namely 1) stakeholders’ involvement in the evaluation
process, 2) specific evaluation question(s), 3) recom-
mended approaches to evaluation; 4) preferred wording
of terms used and formulation of criteria. The six expert
working groups will focus on:
1) General recommendations for implementation of
the evaluation framework
2) Evaluation adaptation with Indigenous communities
3) Evaluation adaptation with caregivers
4) Evaluation adaptation with immigrant populations
5) Evaluation adaptation for patients with physical
and/or intellectual challenges/disabilities
6) Evaluation adaptation for patients with low literacy
levels
These six working groups are by no means extensive,
other pertinent groups may have included participation
from other hardly heard communities as defined by reli-
gion, language, gender identity and expression, sexual
orientation, age, socio-economic status, and from stig-
matized groups such as people using drugs, people living
with HIV, or people experiencing homelessness. Our
work may thus serve as a template to future teams to
adapt the framework to their particular research focus.
The six working groups mobilized within our research
will discuss the experience of their own community of
patient/public partners in order to identify the contexts
and processes that could likely be obstacles or facilita-
tors to contributing engagement practices, and thus out-
line how to adapt the PPE evaluation framework for
these populations. Discussions around the adaptation
and implementation of the general evaluation framework
for PPE will focus on evaluation indicators and standards
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that should be emphasized, added or removed, when en-
gaging with specific populations. Those discussions will
be informed by population-specific analysis of responses
within the Consensus Building Exercise and Delphi
process.
Overall, the consensus meetings will have led to the
construction of the logic model, the Delphi will have set
the SPOR community’s choices for priority process and
outcome indicators, and the expert working-groups will
provide recommendations on adaptation and implemen-
tation of the national framework to specific populations.
Equity, diversity and inclusion
There is strong evidence from the literature that some
patient groups face more barriers than others to engage
in research [25, 27]. For instance, we know that women
are overrepresented in the patient communities and
more so in some health research areas than others (e.g.
[20, 21]). Conversely, people from ethnic minority
groups, living with poverty, or with intellectual disability
face specific barriers to engagement that may hamper
their meaningful involvement in research [19].
Our equity, diversity and inclusion strategy has three
complementary goals:
1. That participants in the development of the
national evaluation framework include a diversity of
perspectives and is inclusive of seldom-heard
populations;
2. That the content of the national evaluation
framework addresses evaluation dimensions that are
informed by equity, diversity and inclusion
considerations;
3. That implementation of the national evaluation
framework is adapted to specific needs and
perspectives of seldom-heard populations.
Therefore, from the start of the project, the research
team will make sure equity is intertwined in each stage
of its design and development. This will involve co-
designing each phase of research with patients from sel-
dom heard populations and experts in the field. Our re-
search team actively recruited experts on equity in PPE
to foster an inclusive design process. Although inclusion
of all perspectives is not feasible, we will pay special at-
tention to 5 seldom-heard groups of particular import-
ance for PPE in research within the Canadian context:
Indigenous communities, new immigrants, people with
intellectual and physical disability, people with low liter-
acy levels, and caregivers.
At phase 1 – Consensus Meeting – a self-
identification questionnaire will help to characterize the
sociodemographic profiles of consensus-building partici-
pants. At this stage of the process, the focus is on the
involvement of participants with expertise and experi-
ence in PPE in research, as identified by SPOR research
entities. We expect this recruitment strategy will reflect
the fact that certain socio-demographic groups are over
or under-represented. By highlighting these profiles, it
will be easier to take note of potential exclusions and to
purposely recruit participants for phases 2 and 3 of the
project. We will also have the opportunity to code the
transcripts of the meetings in order to analyze whether
certain issues of diversity, equity and inclusion emerged,
by whom they were raised and whether these elements
were reflected in the dimensions and criteria chosen to
constitute the logic model.
At phase 2 – Delphi – the research team will recruit
purposefully to ensure that a diversity of perspectives
are represented, both from a sociodemographic point of
view and in terms of patient experience pathway. This
includes recruitment of participants from identified sel-
dom heard groups. We will work to adapt the Delphi
questionnaire in collaboration with representatives of
the five seldom-heard communities to see what kind of
adaptations will need to be made to ease participation as
much as possible. Among other things, we could con-
sider to roll-out the questionnaire in multiple ways, in-
cluding by telephone, to help include participants with
lower literacy or disabilities. A series of identification
questions will help us clarify the profile of Delphi partic-
ipants in order to better understand the differences and
similarities between specific seldom-heard populations
preferences and the general group. In addition to allow-
ing the expert working groups to prepare and guide their
work, this information will help us to better distinguish
between areas of consensus (core evaluation framework)
and areas of dissent (informing guidelines for implemen-
tation and adaptation).
At phase 3 – Experts-working groups – five of six ex-
pert working groups will analyze the simultaneous inter-
actions between different social categories that make up
a patient’s social identity, as well as the impact of power
imbalances on the involvement of individuals who often
carry the burden of illness. Using the list of questions
defined by Shimmin et al. [27], these working groups
will discuss the experience of different communities of
patient partners in research and answer three questions
with the angle of better understanding the specificities
of embarking in PPE evaluation with these populations:
1- Are the evaluation criteria and dimensions
representative of their experience? If yes, why? If
no, what would be more relevant?
2- What evaluation criteria and dimensions should be
emphasized, added or removed when evaluating
PPE in conducting research with your specific
group?
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3- Are there evaluation approaches that need to be
adopted and protocols implemented in order to
adequately embark in the evaluation of PPE?
This project is supported by a research team com-
posed of experts who have been working with these five
communities for several years and who have built trust-
ing relationships with participants. The working groups
will all require a specific strategy to enhance equity and
inclusion. Thus, the first step will be to determine the
terms of the collaboration and to define the best ways of
working together. We do not want to pre-determine this
strategy at the protocol stage. Co-construction is key
and will require us to allocate it time and plan this phase
of the project accordingly.
Adding to the aforementioned analysis, sex- and
gender-based analysis will be led by the research team at
the 3 phases to better understand the gendered nature
of PPE in Canada and how these factors can affect the
process and outcomes of PPE. This health equity explor-
ation will allow for a more inclusive and reflective ap-
proach to PPE evaluation and ease the adaptation and
implementation of the common framework to specific
population needs.
Patient and public engagement
The overarching goal of our engagement strategy
within the project is to enhance the relevance, value
and usefulness of the proposed evaluation framework
to help patients and researchers reflect together on
their research partnership. Patient and public partners
are involved at every level (strategic, tactic and oper-
ational) and phases (research preparation, execution,
and knowledge translation) of this research project.
Research agenda-setting and framing of the initial
project was conducted with the SPOR national patient
and public engagement working group, which in-
cludes patient and public partners from across the
country with extensive experience in supporting en-
gagement in research. Patient partners with extensive
experience in research have been engaged since the
onset as co-principal investigators (AG) and co-
investigators (CC) on the research team and contrib-
uted to study design, protocol development and fund-
ing application; they will also contribute to ongoing
development of study instruments (eg. consensus
meeting questions, Delphi survey), recruitment strat-
egies, data interpretation and knowledge translation.
Patient and public partners from the 18 national
SPOR Networks, SUPPORT Units and research orga-
nizations collaborating on this project will be involved
in consensus meetings to design the initial evaluation
framework template and logic model, alongside 2 na-
tional patient leaders from the Patient Advisors
Network, an independant community of people who
have received health services or cared for those who
are, committed to improving healthcare as advisors
across Canada. These patient and public collaborators
will further be engaged in the recruitment of partici-
pants in the Delphi survey, as well as in the dissemin-
ation and implementation of the framework within
their organizations and communities. Finally, patient
and public partners will act as co-leads of the work-
ing groups on equity, inclusion and diversity (de-
scribed above), contributing to its design, structure,
recruitment, facilitation and approval of recommanda-
tions. Evaluation of our patient and public engage-
ment dynamics (team interaction, support,
contribution, feeling valued, convenience, research en-
vironment, procedural requirements and benefits) will
be conducted at the end of every stage of the project,
using the Patient Engagement in Research Scale [16,
17] with additional questions on the experiences of
online engagement, in order to support reflexivity and
improvement of our own engagement practices within
the project.
Research in time of COVID-19
Current health challenges around the world have asked
us to reconsider the timeline of this project to allow for
the logistical adaptations necessary to comply with pub-
lic health guidelines while maintaining methodological
rigor. At the time of publication of this protocol, the first
phase of the project will be well underway and consen-
sus meetings should be completed and the transcripts
being analyzed. The transition from a face-to-face to a
virtual setting will have lengthened this phase of the pro-
ject from what was originally planned, delaying the Del-
phi phase by approximately 3 months. The deployment
of Delphi is planned for the spring of 2021 for the first
round and the summer of 2021 for the second round. Its
preparation (recruitment strategy and logistics, question-
naire development, participant recruitment, etc.) is
therefore planned for the winter of 2021. As for the ex-
pert working groups, all six of them ask for a specific
strategy to strengthen and promote the participation and
inclusion of the communities involved. In light of this,
this last phase will take place between the months of
May and December 2021. This 6-month period should
give us enough time to adapt the form and pace of the
work to the needs of each of these groups of partici-
pants. The complete project was originally planned for a
one-year period; the COVID-19 pandemic therefore re-
quired us to re-plan for an 18-month period.
Discussion
The project’s potential contributions are threefold: 1)
support capacity building for evaluation of PPE within
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the Canadian research community; 2) inform the inter-
national research community on potential virtual meth-
odologies to build national consensus on common
evaluation frameworks; and 3) illustrate a shared attempt
to engage patients and researchers in a strategic national
initiative to strengthen evaluation of PPE.
As early as 1993, Butterfloss et al. called for a
systemization and better understanding of what charac-
teristics of collaborative endeavours lead to producing
short and long-term impacts on the communities they
serve. More recently, Barber et al. [5] demonstrated the
benefits of a structured evaluation towards providing
evidence on the influence of patient and public engage-
ment on researchers, research processes and research
products. For research funders such as CIHR and patient
and public engagement capacity building organizations
such as SPOR SUPPORT Units and Networks, this pro-
ject will provide tools to improve monitoring activities,
better support PPE in research and offer guidance to im-
prove PPE activities. For patients and members of the
public, this project will offer them mechanisms to foster
collaboration and feedback loops, contributing simultan-
eously to patients’ empowerment and competence build-
ing [23]. This common evaluation framework will
facilitate collaboration, cross-learning and strengthen
PPE in research across Canada, while allowing for local
adaptations to contexts, populations and engagement ap-
proaches. It will help to catalyze best practices and com-
mon strategies for PPE implementation and evaluation
across the Canadian research community, all the while
encouraging continuous reflection on the actions needed
to build learning health systems that truly consider and
reflect the needs, priorities and perspectives of patients,
communities and citizens.
Since transferability across contexts of PPE evaluation
frameworks is difficult and potentially inappropriate, the
methods used to generate national consensus (the how)
may be more transferable than the evaluation frame-
works themselves (the results). We share our “how to”
protocol hoping to inspire other groups seeking to de-
velop their own PPE evaluation framework with patients
and research partners. Co-designing evaluation frame-
works and measures could support common under-
standing of teams regarding the evaluation of patient
and public engagement, increase their ability to engage
in evaluation, and foster the learning potential resulting
from the evaluation process.
This protocol has been co-constructed in partnership
with patients who have experience working in health re-
search. In the past years, the evolution of the Canadian
research community, their increasing capacities to en-
gage patients in more meaningful ways and the increased
number of patient partners active and dedicated to im-
proving research all helped conceive a protocol that
reflects the complexity and the maturity of the Canadian
patient-oriented research community. This project con-
sists in a multi-phase process that, while anchored in the
growing science of PPE, stems from the experiences of
the researchers and patient partners that make up our
community. This protocol therefore illustrates a shared
attempt from patients and researchers to move forward
in building common engagement evaluation criteria and
standards.
The research team benefits from an unparalleled level
of expertise and networking within the SPOR commu-
nity. All members of the research team maintain privi-
leged relationships with the SPOR Units and Networks,
if not themselves leaders in them. In addition, we are
building this project upon a 4-year collaboration be-
tween PPE leaders across the country that stemmed
from a previous Evaluation Toolkit Project. These col-
laborations will accelerate the coordination of consensus
activities. The SPOR Units and Networks will also be
our crucial relays to disseminate the Delphi question-
naires throughout the Canadian patient-oriented re-
search community.
Our proposed approach has several limitations. For ex-
ample, we are aware of the constraints imposed by the
COVID-19 pandemic. For the consensus exercise, which
was previously designed to take place in person, the
transfer in virtual mode will pose a challenge in building
a relationship with participants through a video confer-
encing platform, a barrier that could be amplified for
people with low digital literacy or limited access to tech-
nologies. In adapting to an online mode for the consen-
sus building exercise, we will adopt three additional
mechanisms to facilitate participation: 1) we will hire a
research assistant to further support participants and an-
swer clarifying questions by phone or email; 2) host an
orientation meeting previous to the actual consensus
building exercise; and 3) set up an informal chat line
(e.g. Slack) to allow participants to exchange informally,
and allow for another mode of communication with the
research team. This limitation is a hypothesis rather than
an assertion, as only experience will allow us to judge
the impact of this transition from face-to-face to virtual
consensus-building (e.g. it may decrease barriers to par-
ticipation for geographical and transportation concerns,
and those with caregiver responsibilities). There may
even be positive aspects, such as increased participant
availability, home comfort, and reflection time between
meetings. We will therefore make sure to reflect on the
experience of the participants, especially the patient
partners, at the end of each phase of the project in order
to learn from the process.
Furthermore, although explicit consideration of equity,
diversity and inclusion (and its integration in all phases
of the project) is a potential strength, we are also
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conscious that some groups may nonetheless be ex-
cluded because of systemic barriers to participation, in-
cluding recruitment of people with existing engagement
experience through research networks, complexity of the
concepts being discussed, power dynamics within group
processes and choice of a Delphi process to generate
consensus based on majorities’ vote. To mitigate these
potential limitations, we will: 1) work with seldom-heard
groups and experts in engagement equity to inform and
analyse the framework development process; 2) docu-
ment whose voices may be under-represented and lost
through voting, by using sub-group analysis; and 3)
complement the national framework with a set of rec-
ommendations for adaptation to specific seldom-heard
populations. Our process for deliberately engaging with
target groups known to experience barriers for engage-
ment (e.g. immigrants and Indigenous communities)
within the current project could furthermore serve as a
template for complementary projects with other
communities.
Conclusion
The science of PPE is evolving rapidly, yet it remains at
an early stage and is challenging to apply within the
Canadian research landscape. Concrete ways to guide
the production of robust, rigorous and systematic evalu-
ation on PPE in research is at the core of this project.
Building a national yet adaptable evaluation framework
is an essential precondition for comparable PPE evalu-
ation projects, a core missing piece for PPE in Canada.
Built-in adaptation to specific populations will allow for
more equity and diversity, while tailoring an adaptation
process that could be applied to other populations in fu-
ture versions of the framework. Apart from contributing
to the emerging international science of PPE in research,
this project will help national practitioners of PPE (orga-
nizations, engagement leads, researchers, patients) to
conduct rigorous PPE evaluation, share experiences,
learn from engagement initiatives, and report on PPE ac-
tivities and outcomes in a systematic manner.
While this approach has a Canadian focus, the process
of developing the evaluation framework could inform
similar consensus-building processes in other national
and international settings. We see here an opportunity
nested at the heart of the science of PPE to share our re-
search and evaluation methods as much as our results.
This will allow both a better understanding of the PPE
evaluation products (tools or frames) and a greater abil-
ity for PPE specialists to adapt them or craft their own.
PPE in research is multifaceted and, according to us, it
would be threatening to the very nature of PPE to make
it a “one-size-fits-all” model. However, the right ap-
proach to building an evaluation strategy will ensure that
each initiative keeps it’s uniqueness while providing the
PPE community with methods to more systematically
and globally understand and learn from experiences.
This protocol is therefore our proposal for such an ap-
proach, intended to be common and adaptable, and to
result in a national minimal structure for the evaluation
of PPE in research.
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